(Q54628923)

1 June 2018

title

Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib. (English)

1 reference

1 June 2018

1 reference

3

1 reference

1 June 2018

Elena Palassini

6

1 reference

1 June 2018

Paola Collini

7

1 reference

1 June 2018

Carlo Morosi

9

1 reference

1 June 2018

Alessandro Gronchi

10

1 reference

1 June 2018

Paolo Giovanni Casali

12

1 reference

1 June 2018

Silvia Stacchiotti

object named as

Silvia Stacchiotti

1

0 references

Silvana Pilotti

11

object named as

Silvana Pilotti

1 reference

1 June 2018

Elena Conca

4

object named as

Elena Conca

1 reference

1 June 2018

author name string

Florence Pedeutour

2

1 reference

1 June 2018

Andrea Marrari

5

1 reference

1 June 2018

Frederique Keslair

8

1 reference

1 June 2018

language of work or name

English

0 references

publication date

8 March 2011

1 reference

1 June 2018

International Journal of Cancer

published in

1 reference

1 June 2018

volume

129

1 reference

1 June 2018

issue

7

1 reference

1 June 2018

page(s)

1761-1772

1 reference

1 June 2018

Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002.

cites work

1 reference

Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution

21 January 2018

1 reference

Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate

21 January 2018

1 reference

Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities

21 January 2018

1 reference

Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance

21 January 2018

1 reference

The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans

21 January 2018

1 reference

Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma.

21 January 2018

1 reference

Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans.

21 January 2018

1 reference

Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.

21 January 2018

1 reference

Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans

21 January 2018

1 reference

Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials

21 January 2018

1 reference

Value of cytogenetic analysis in the treatment of dermatofibrosarcoma protuberans

21 January 2018

1 reference

Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.

21 January 2018

1 reference

Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate

21 January 2018

1 reference

Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer

21 January 2018

1 reference

Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas

21 January 2018

1 reference

Response to sunitinib malate in advanced alveolar soft part sarcoma

21 January 2018

1 reference

Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis

21 January 2018

1 reference

PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor

21 January 2018

1 reference

High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

21 January 2018

1 reference

Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?

21 January 2018

1 reference

Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS.

21 January 2018

1 reference

COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans

21 January 2018

1 reference

Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients

21 January 2018

1 reference

Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST).

21 January 2018

1 reference

Connecting autophagy to senescence in pathophysiology.

21 January 2018

1 reference

Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans

21 January 2018

1 reference

Molecular and Cytogenetic Subgroups of Oropharyngeal Squamous Cell Carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25826

1 reference

1 June 2018

1 reference

1 June 2018